Colgate-Palmolive (CL) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.99
- Estimate
- $0.95
- Surprise
- +4.5%
- Revenue (period 2026-06-30)
- $5.36B
- Score at report (before → after)
- 5.5 → 5.6/10
Revenue source: xbrl.
How the report landed
Colgate-Palmolive (CL) beat the $0.95 estimate with diluted EPS of $0.99 — a clear 4.5% upside surprise. TrendMatrix's engine moved from Data Issue (5.5/10) to Hold at 5.6/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CL Sell at 4.9/10.
4 of the last 4 quarters beat the estimate; this quarter's +4.5% surprise compares with a +3.4% four-quarter average. Next scheduled report: 2026-10-30.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.6 in RISK_OFF)
- Sector modifier (Consumer Defensive): +0.8
What argues against it
- Analyst target reached - limited upside remaining
- Leverage penalty (D/E 13.9): -1.5
- Weak overall score: 4.9/10
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $90.08
- Price target
- $92.00
- Stop
- $87.06
- Upside to target
- +2.1%
The stock trades at 35.5× trailing but 21.9× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
CL at TrendMatrix's latest read
Defensive staples are judged on margin resilience: pricing power against input costs matters more here than top-line drama.
- Industry
- Household & Personal Products
- Market cap
- $71.82B
- P/E (fwd)
- 21.9
- P/E (ttm)
- 35.5
- 52-week range
- $74.55–$99.33
- Off 52-week high
- 9.3%
- RSI (14)
- 49
- Volume vs avg
- 0.09×
- Score today
- 4.9/10